Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanfang Guan

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
BMC Cancer|May 9, 2025
Development and application of a whole transcriptome sequencing assay for the detection of gene fusions in clinical cancer specimensSongchen Zhao, Xinhua Du, Yan Zhang, et al.
Cancers|November 26, 2022
Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung CancerYiting Dong, Yixiang Zhu, Minglei Zhuo, et al.
Frontiers in Immunology|September 9, 2020
<i>CCND1</i> Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid TumorsYu Chen, Yingying Huang, Xuan Gao, et al.
American Journal of Cancer Research|October 17, 2018
Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancerHuiping Li, Yaping Xu, Fangyuan Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinomaDong Wang, Yaping Xu, Jennifer B Goldstein, et al.
Molecular Oncology|June 6, 2020
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumorsYu Chen, Yi Li, Yanfang Guan, et al.
Cancer Biology & Therapy|March 28, 2018
A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapyQiuli Liu, Dali Tong, Gaolei Liu, et al.
Annals of Translational Medicine|July 11, 2020
Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinomaFei Wang, Xiaohong Xie, Mengmeng Song, et al.
Journal of Cellular and Molecular Medicine|August 9, 2019
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancerPuyuan Xing, Xiaohong Han, Sha Wang, et al.
Journal of Cancer|April 4, 2022
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinomaXiaonan Wu, Jun Zhao, Ling Yang, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
BMC Cancer|May 9, 2025
Development and application of a whole transcriptome sequencing assay for the detection of gene fusions in clinical cancer specimensSongchen Zhao, Xinhua Du, Yan Zhang, et al.
Cancers|November 26, 2022
Maximum Somatic Allele Frequency-Adjusted Blood-Based Tumor Mutational Burden Predicts the Efficacy of Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung CancerYiting Dong, Yixiang Zhu, Minglei Zhuo, et al.
Frontiers in Immunology|September 9, 2020
<i>CCND1</i> Amplification Contributes to Immunosuppression and Is Associated With a Poor Prognosis to Immune Checkpoint Inhibitors in Solid TumorsYu Chen, Yingying Huang, Xuan Gao, et al.
American Journal of Cancer Research|October 17, 2018
Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancerHuiping Li, Yaping Xu, Fangyuan Zhao, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2020
Preoperative evaluation of microvascular invasion with circulating tumour DNA in operable hepatocellular carcinomaDong Wang, Yaping Xu, Jennifer B Goldstein, et al.
Molecular Oncology|June 6, 2020
Prevalence of PRKDC mutations and association with response to immune checkpoint inhibitors in solid tumorsYu Chen, Yi Li, Yanfang Guan, et al.
Cancer Biology & Therapy|March 28, 2018
A novel BRCA2 mutation in prostate cancer sensitive to combined radiotherapy and androgen deprivation therapyQiuli Liu, Dali Tong, Gaolei Liu, et al.
Annals of Translational Medicine|July 11, 2020
Tumor immune microenvironment and mutational analysis of tracheal adenoid cystic carcinomaFei Wang, Xiaohong Xie, Mengmeng Song, et al.
Journal of Cellular and Molecular Medicine|August 9, 2019
Co-mutational assessment of circulating tumour DNA (ctDNA) during osimertinib treatment for T790M mutant lung cancerPuyuan Xing, Xiaohong Han, Sha Wang, et al.
Journal of Cancer|April 4, 2022
Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinomaXiaonan Wu, Jun Zhao, Ling Yang, et al.
Pageof 13